NCT03463668 Evaluation of the Efficacy of Duodenal Prostheses Not Covered Over 6 Years
| NCT ID | NCT03463668 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut Paoli-Calmettes |
| Condition | Digestive or Non-digestive Neoplasia Leading to Symptomatic Duodenal Stenosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2017-12-22 |
| Primary Completion | 2029-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2017-12-22 with a primary completion date of 2029-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To assess the efficacy of duodenal prostheses for duodenal stenosis established for endoscopic pyloric or duodenal stenosis on dysphagia
Eligibility Criteria
Inclusion Criteria: * Any symptomatic duodenal stenosis with symptomatic duodenal duodenal prosthesis between 2010 and 2017. Exclusion Criteria: * Benign stenosis or covered metallic duodenal prosthesis (usually indicated for benign disease)
Contact & Investigator
Fabrice CAILLOL
PRINCIPAL INVESTIGATOR
Institut Paoli-Calmettes
Frequently Asked Questions
Who can join the NCT03463668 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Digestive or Non-digestive Neoplasia Leading to Symptomatic Duodenal Stenosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03463668 currently recruiting?
Yes, NCT03463668 is actively recruiting participants. Contact the research team at CAILLOLF@ipc.unicancer.fr for enrollment information.
Where is the NCT03463668 trial being conducted?
This trial is being conducted at Marseille, France.
Who is sponsoring the NCT03463668 clinical trial?
NCT03463668 is sponsored by Institut Paoli-Calmettes. The principal investigator is Fabrice CAILLOL at Institut Paoli-Calmettes. The trial plans to enroll 200 participants.